Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  PuriCore plc    PURI   GB00B3XBCR18

Delayed Quote. Delayed  - 09/29 05:35:26 pm
30.5 GBp   --.--%
09/20 PURICORE : Offloads Supermarket Retail Arm, Interim Loss Widens
08/17 PURICORE : Granted Two US Patents For Skin Disorder Therapy Producti..
06/09 PURICORE : To Submit New Drug Application For PR022 To FDA In 2017
 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
09/23/2016 09/26/2016 09/27/2016 09/28/2016 09/29/2016 Date
30.5(c) 30.5(c) 30.5(c) 30.5(c) 30.5(c) Last
58 608 10 889 600 4 864 11 620 Volume
+5.17% 0.00% 0.00% 0.00% 0.00% Change
More quotes
Company
PuriCore Plc engages in the development and provision of water-based clean technology decontamination solutions.It operates through the following Supermarket Retail and Health Science segments.The Supermarket Retail segment provides products extending the shelf life of fresh produce.The Health... 
More about the company
Latest news on PURICORE PLC
09/20 PURICORE : Offloads Supermarket Retail Arm, Interim Loss Widens
08/17 PURICORE : Granted Two US Patents For Skin Disorder Therapy Production
06/09 PURICORE : To Submit New Drug Application For PR022 To FDA In 2017
05/27 PURICORE : To Stop Selling ProduceFresh Until Registered As Pesticide
04/14 PURICORE : Appointment of Dr. Christian Peters as Chief Medical Officer
04/14 PURICORE : Appoints Christian Peters As Chief Medical Officer
03/29 PURICORE : CEO Buys 100,000 Shares (DIRECTOR DEALINGS)
03/29 PURICORE : Good progress
03/29 PURICORE : Good progress Biopharmaceutical company PuriCore,
03/24 PURICORE : Considers Spin-Off Of Supermaket Retail Unit As Revenue Rises
More news
Sector news : Biotechnology & Medical Research - NEC
09/29DJARROWHEAD PHARMACEUTICALS : Amgen, Arrowhead Pharma Agree to Cardiovascular Coll..
09/27DJAMGEN : Myeloma Treatment Study Fails to Meet Primary Endpoint
09/26DJSANOFI : FDA Accepts Sanofi's, Regeneron's Dermatitis Treatment for Priority Rev..
09/23DJAMGEN : FDA Approves Amgen's Biosimilar Version of Humira -- 2nd Update
09/23DJAMGEN : FDA Approves Amgen's Biosimilar Version of Humira -- Update
More sector news : Biotechnology & Medical Research - NEC
Advertisement
Chart PURICORE PLC
Duration : Period :
PuriCore plc Technical Analysis Chart | PURI | GB00B3XBCR18 | 4-Traders
Full-screen chart
Managers
NameTitle
John Alexander Martin Chief Executive Officer & Executive Director
Charles Alexander Evan Spicer Non-Executive Chairman
Marella Thorell COO, CFO, Secretary & Executive Director
Christian Peters Chief Medical Officer
Joseph William Birkett Senior Independent Non-Executive Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
PURICORE PLC54.43%20
INCYTE CORPORATION-14.90%17 351
CELLTRION, INC.--.--%11 458
LONZA GROUP AG13.30%10 115
QUINTILES TRANSNATIONA..15.15%9 411
SEATTLE GENETICS, INC.18.74%7 488
More Results